Recent studies show that targeting PTBP1 by ASOs can convert midbrain ACs to dopaminergic neurons and improved Parkinson’s disease in mice (45), and that PTBP1 knockdown promotes neuronal-like differentiation of IDH-WT GBM cell lines (59). Here, PTBP1 is linked to glioblastoma.